Growth Metrics

Angiodynamics (ANGO) Return on Invested Capital (2016 - 2025)

Angiodynamics (ANGO) has disclosed Return on Invested Capital for 15 consecutive years, with 0.18% as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Return on Invested Capital rose 97.0% year-over-year to 0.18%, compared with a TTM value of 0.18% through Nov 2025, up 97.0%, and an annual FY2025 reading of 0.21%, up 38.0% over the prior year.
  • Return on Invested Capital was 0.18% for Q4 2025 at Angiodynamics, up from 0.21% in the prior quarter.
  • Across five years, Return on Invested Capital topped out at 0.01% in Q3 2023 and bottomed at 1.2% in Q3 2024.
  • Average Return on Invested Capital over 5 years is 0.29%, with a median of 0.1% recorded in 2023.
  • The sharpest move saw Return on Invested Capital crashed -121bps in 2024, then skyrocketed 99bps in 2025.
  • Year by year, Return on Invested Capital stood at 0.09% in 2021, then grew by 15bps to 0.07% in 2022, then surged by 61bps to 0.03% in 2023, then plummeted by -3956bps to 1.15% in 2024, then surged by 84bps to 0.18% in 2025.
  • Business Quant data shows Return on Invested Capital for ANGO at 0.18% in Q4 2025, 0.21% in Q3 2025, and 0.21% in Q2 2025.